Healthcare & Life Sciences
ABclonal
Chinawww.abclonal.com/
ABclonal is a Healthcare & Life Sciences startup based in China, most recent round Series C+, 5 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2012
Founded
5
Investors
About ABclonal
ABclonal is a company founded in 2012 headquartered in China. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
ABclonal is a biotechnology company specializing in the production of high-quality reagents, antibodies, proteins, and immunoassays for research and diagnostic applications.
Explore ABclonal's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.